- Twice-daily telaprevir for posttransplant genotype 1 hepatitis C virus: A prospective safety, efficacy, and pharmacokinetics study. Experimental and Clinical Transplantation. 2018 Academic Article GET IT
Persistence of virologic response after liver transplant in hepatitis c patients treated with ledipasvir/sofosbuvir plus ribavirin pretransplant.
Annals of Hepatology.
Times cited: 2